日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig

与 CTLA4-Ig 相比,选择性 CD28 阻断可更有效地抑制供体特异性滤泡辅助性 T 细胞和抗体反应。

Badell, I R; La Muraglia, G M 2nd; Liu, D; Wagener, M E; Ding, G; Ford, M L

Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy

病原体刺激史影响供体特异性CD8(+) T细胞对基于共刺激/整合素阻断疗法的敏感性

Badell, I R; Kitchens, W H; Wagener, M E; Lukacher, A E; Larsen, C P; Ford, M L

Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy

贝拉西普和西罗莫司可延长非人灵长类动物胰岛同种异体移植的存活时间:同时使用阿来法塞普治疗的不良后果

Lowe, M C; Badell, I R; Turner, A P; Thompson, P W; Leopardi, F V; Strobert, E A; Larsen, C P; Kirk, A D

CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8

CTLA4Ig可防止使用CD40特异性抗体3A8进行非人灵长类动物胰岛移植后形成同种异体抗体。

Badell, I R; Russell, M C; Cardona, K; Shaffer, V O; Turner, A P; Avila, J G; Cano, J A; Leopardi, F V; Song, M; Strobert, E A; Ford, M L; Pearson, T C; Kirk, A D; Larsen, C P

Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates

非耗竭性抗CD40疗法可延长非人灵长类动物同种异体移植的存活时间

Badell, I R; Thompson, P W; Turner, A P; Russell, M C; Avila, J G; Cano, J A; Robertson, J M; Leopardi, F V; Strobert, E A; Iwakoshi, N N; Reimann, K A; Ford, M L; Kirk, A D; Larsen, C P

A novel monoclonal antibody to CD40 prolongs islet allograft survival.

一种新型的抗CD40单克隆抗体可延长胰岛同种异体移植的存活时间

Lowe M, Badell I R, Thompson P, Martin B, Leopardi F, Strobert E, Price A A, Abdulkerim H S, Wang R, Iwakoshi N N, Adams A B, Kirk A D, Larsen C P, Reimann K A

CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates

CD40特异性共刺激阻断可提高非人灵长类动物新生猪胰岛的存活率

Thompson, P; Cardona, K; Russell, M; Badell, I R; Shaffer, V; Korbutt, G; Rayat, G R; Cano, J; Song, M; Jiang, W; Strobert, E; Rajotte, R; Pearson, T; Kirk, A D; Larsen, C P

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation

使用基于依法利珠单抗的新型免疫抑制方案促进单供体胰岛细胞移植的经验

Turgeon, N A; Avila, J G; Cano, J A; Hutchinson, J J; Badell, I R; Page, A J; Adams, A B; Sears, M H; Bowen, P H; Kirk, A D; Pearson, T C; Larsen, C P